Authors


Eva Culakova, PhD

Latest:

Variation in the Cost of Medications for the Treatment of Colorectal Cancer

Using data from a nationwide registry, this study revealed significant variation in the use and cost of contemporary regimens for colorectal cancer.





Dominick Esposito, PhD

Latest:

Medicaid Beneficiaries With Congestive Heart Failure: Association of Medication Adherence With Healthcare Use and Costs

Higher medication adherence among Medicaid beneficiaries with congestive heart failure was associated with lower healthcare utilization and lower costs, and the relationship to costs was graded.


Angelia Szwed

Latest:

Heart Failure Needs More Attention in Diabetes Drug Trials, Expert Says

At a symposium at the 77th Scientific Sessions of the American Diabetes Association, experts suggested that the relationship between heart failure and diabetes is finally getting the attention it deserves.


Sven Streit, MD

Latest:

Patient Complexity Characteristics in the Hospital Setting

This multicenter study identifies patient complexity in the hospital setting as frequent and helps to better understand what makes a patient complex.



Brent D. Fulton, PhD, MBA

Latest:

Countywide Physician Organization Learning Collaborative and Changes in Hospitalization Rates

The University of Best Practices physician organization learning collaborative in San Diego County was associated with lower hospitalization rates for heart attacks.



Keith Latham, PharmD

Latest:

Authors’ Reply to “Comment on Generalizability of GLP-1 RA CVOTs in US T2D Population”

The authors of the manuscript “Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population” respond to a letter to the editor.





Amy Byer Shainman

Latest:

Do What I Couldn't…and Go Save Your Life

Amy Byer Shainman narrates how the knowledge that she was BRCA1 positive led to her decision to undergo prophylactic surgery.


Abigail G. Matthews, PhD

Latest:

Technology-Driven Intervention to Improve Hypertension Outcomes in Community Health Centers

Health information technology that is implemented as part of a multifaceted quality improvement initiative can lead to improvements in hypertension care and outcomes.


Michael Koffler, MBA

Latest:

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings

Pharmacy and medical claims data showed that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.




Richard Lam, MD, MBA

Latest:

Older Adult Consumers' Attitudes and Preferences on Electronic Patient-Physician Messaging

A randomized controlled trial was conducted to assess whether adding a peer testimonial to a mailing increases conversion rates from brand name prescription medications to lower-cost equivalents.




Stephen P. Wall, MD, MS, MAEd

Latest:

Reasons for Emergency Department Use: Do Frequent Users Differ?

Frequent emergency department (ED) users gave similar reasons for using the ED rather than a clinic compared to other patients, including concerns around convenience, access, and quality.


Tim Day, MSPH

Latest:

Effects of a Community-Based Care Management Model for Super-Utilizers

A community-based care management program for high-risk patients reduced hospital readmissions and also likely reduced admissions and Medicare parts A and B spending.





Rita L. Hui, PharmD, MS

Latest:

Trends in Bisphosphonate Initiation Within an Integrated Healthcare Delivery System

The authors observed a marked shift toward treatment of higher-risk subsets of younger postmenopausal women (with prior fracture and/or with osteoporosis), and away from women at lower risk.


Engels N. Obi, PhD

Latest:

Placement of Selected New FDA-Approved Drugs in Medicare Part D Formularies, 2009-2013

There is significant heterogeneity in formulary placement and restrictions on new drug approvals in the Part D marketplace.


Patricia J. Zettler, JD

Latest:

The Challenge of Paying for Cost-Effective Cures

For cost-effective cures, the drug pricing policy challenge is not simply to lower prices, but also to spread the drug costs among payers.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo